Bornstein, E., Lenchner, E., Donnenfeld, A., Barnhard, Y., Seubert, D. and Divon, M. (2009) Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice. Journal of Perinatal Medicine, 37, 99-102.

has been cited by the following article:

• TITLE: Fetal loss rates after mid-trimester amniocentesis

  AUTHORS: Ilker Arikan, Muge Harma, Aykut Barut, Mehmet Ibrahim Harma, Ulku Bayar

  KEYWORDS: Genetic Amniocentesis; Mid-Trimester Amniocentesis; Pregnancy Loss; Amniocentesis- Related Fetal Loss

  JOURNAL NAME: Health, Vol.2 No.4, May 4, 2010

  ABSTRACT: Objective: Amniocentesis is an invasive cytogenic test traditionally associated with a 1/200 procedure–related pregnancy loss rate. Recent studies have questioned the validity of the traditionally stated rate. The purpose of this study was to document the results of second-trimes- ter genetic amniocentesis performed at our pe- rinatalogy clinic. Study Design: A retrospective review of all the amniocentesis procedures per- formed between 15 and 22 weeks of gestation on singleton pregnancies between May 2004 and December 2008 was performed. Spontaneous loss was defined as any unintentional preg- nancy loss at